Safety of Anticoagulation Interruption in Patients Undergoing Surgery or Invasive Procedures: A Systematic Review and Meta-analyses of Randomized Controlled Trials and Non-randomized Studies.

about

Safety of Anticoagulation Interruption in Patients Undergoing Surgery or Invasive Procedures: A Systematic Review and Meta-analyses of Randomized Controlled Trials and Non-randomized Studies.

Item

http://www.wikidata.org/entity/Q38728496

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Safety of Anticoagulation Inte ...... ls and Non-randomized Studies.

@en

type

Item

label

Safety of Anticoagulation Inte ...... ls and Non-randomized Studies.

@en

prefLabel

Safety of Anticoagulation Inte ...... ls and Non-randomized Studies.

@en

P1476

Safety of Anticoagulation Inte ...... als and Non-randomized Studies

@en

P2093

Donat R Spahn

http://www.w3.org/2001/XMLSchema#string

Sabrina Köppel

http://www.w3.org/2001/XMLSchema#string

P2860

Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Meta-analysis of bleeding complications associated with cardiac rhythm device implantation

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association.

Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.

Subgroup effects despite homogeneous heterogeneity test results.

Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention o

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

P2888

s00268-017-4072-x

P304

2444-2456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S00268-017-4072-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Frédérique Hovaguimian

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085989968

http://www.w3.org/2001/XMLSchema#string

P698

28608011

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

meta-analysis